Table 2. Multivariate analysis of variables that influence thromboprophylaxis use in hospitalized cancer patients.

Variables	OR (CI 95%)	p
Hospital stay ≥ 4 days	2.36 (1.76–3.16)	< 0.001
Advanced tumour stage	1.60 (1.15–2.22)	0.005
Active chemotherapy treatment	2.06 (1.45–2.94)	< 0.001
Platelets < 50 x109/L	0.2 (0.12–0.41)	< 0.001
Haemoglobin ≤10g/dl	0.69 (0.50–0.95)	0.026
Hematologic tumour (vs Solid)	0.38 (0.26–0.57)	< 0.001